BIB

Ultra Nasdaq Biotechnology

Investment Objective

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

Daily Return during Q1 2024

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker BIB
  • Intraday Ticker BIB.IV
  • CUSIP 74347R214
  • Inception Date 4/7/10
  • Gross Expense Ratio 1.15%
  • Net Expense Ratio 0.95%
  • NAV Calculation Time 4:00 p.m. ET
  • Distributions Quarterly
Price
as of 3/28/2024
  • NAV $57.53
  • NAV Change $-0.42 down caret
  • Market Price $57.54
  • Market Price Change $-0.55 down caret
  • Trading Volume (M) 34,738
  • 30-Day Median Bid Ask Spread 0.00%
  • View Premium / Discount
Snapshot
  • Ticker BIB
  • Intraday Ticker BIB.IV
  • CUSIP 74347R214
  • Inception Date 4/7/10
  • Expense Ratio 0.95%
  • Gross Expense Ratio 1.15%
  • NAV Calculation Time 4:00 p.m. ET
  • Distributions Quarterly
Price
as of 3/28/2024
  • NAV $57.53
  • NAV Change $-0.42 down caret
  • Market Price $57.54
  • Market Price Change $-0.55 down caret
  • Trading Volume (M) 34,738
  • 30-Day Median Bid Ask Spread 0.00%
  • View Premium / Discount

The expense ratio above has a contractual waiver ending 9/30/24.

Exposures

Index as of 12/29/2023

Holdings

as of 3/27/2024

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
52.12% -- NASDAQ BIO INDEX SWAP BNP 50,595,708 -- 11,380 --
24.90% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 24,168,565 -- 5,436 --
23.64% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 22,950,355 -- 5,162 --
15.27% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 14,823,031 -- 3,334 --
6.05% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 5,873,192 -- 1,321 --
5.91% -- AMGEN INC COMMON STOCK USD 0.0001 -- $5,739,742.40 20,048 --
5.73% GILD GILEAD SCIENCES INC -- $5,558,981.40 76,140 2369174
5.66% REGN REGENERON PHARMACEUTICALS -- $5,491,482.90 5,683 2730190
5.61% VRTX VERTEX PHARMACEUTICALS INC -- $5,445,191.36 13,048 2931034
4.77% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 4,632,753 -- 1,042 --
3.13% -- NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC 3,036,632 -- 683 --
3.05% MRNA MODERNA INC -- $2,961,268.43 26,777 BGSXTS3
2.87% -- ASTRAZENECA PLC ADR USD -- $2,785,554.08 40,808 --
2.27% BIIB BIOGEN INC -- $2,203,855.58 10,187 2455965
1.59% ILMN ILLUMINA INC -- $1,544,201.80 11,135 2613990
1.40% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,362,800.53 8,827 B00FWN1
1.21% BMRN BIOMARIN PHARMACEUTICAL INC -- $1,171,512.81 13,221 2437071
1.01% VTRS VIATRIS INC -- $984,539.92 83,224 BMWS3X9
0.99% NBIX NEUROCRINE BIOSCIENCES INC -- $961,364.25 6,975 2623911
0.98% RPRX ROYALTY PHARMA PLC- CL A -- $953,237.25 31,305 BMVP7Y0
0.98% SNY SANOFI-ADR -- $951,019.38 19,197 2964557
0.93% INCY INCYTE CORP -- $898,840.32 15,736 2471950
0.90% MEDP MEDPACE HOLDINGS INC -- $869,450.12 2,156 BDCBC61
0.90% ARGX ARGENX SE - ADR -- $869,324.79 2,181 BDVLM39
0.88% SRPT SAREPTA THERAPEUTICS INC -- $856,652.94 6,578 B8DPDT7
0.83% UTHR UNITED THERAPEUTICS CORP -- $802,547.73 3,299 2430412
0.65% BNTX BIONTECH SE-ADR -- $630,801.45 6,785 BK6H543
0.63% ROIV ROIVANT SCIENCES LTD -- $612,178.16 56,474 BMW4NZ9
0.62% ASND ASCENDIS PHARMA A/S - ADR -- $597,471.00 4,025 BV9G6B8
0.54% JAZZ JAZZ PHARMACEUTICALS PLC -- $526,387.68 4,368 B4Q5ZN4
0.54% PCVX VAXCYTE INC -- $520,326.00 7,596 BKPVGH6
0.53% CYTK CYTOKINETICS INC -- $515,365.97 7,217 BBBSBJ5
0.52% EXEL EXELIXIS INC -- $507,001.14 21,249 2576941
0.51% APLS APELLIS PHARMACEUTICALS INC -- $494,357.48 8,452 BYTQ6X1
0.49% ITCI INTRA-CELLULAR THERAPIES INC -- $473,119.92 6,786 BHCB0P4
0.47% IONS IONIS PHARMACEUTICALS INC -- $456,246.56 10,216 BDJ0LS6
0.46% BGNE BEIGENE LTD-ADR -- $450,042.16 2,902 BYYWPW6
0.42% BPMC BLUEPRINT MEDICINES CORP -- $406,838.68 4,292 BWY52P3
0.41% CRSP CRISPR THERAPEUTICS AG -- $394,720.16 5,626 BDHF4K6
0.39% BBIO BRIDGEBIO PHARMA INC -- $380,256.92 12,322 BK1KWG8
0.38% RVMD REVOLUTION MEDICINES INC -- $366,143.96 11,543 BL71K91
0.37% HALO HALOZYME THERAPEUTICS INC -- $361,967.51 8,887 2975098
0.37% MDGL MADRIGAL PHARMACEUTICALS INC -- $361,039.95 1,395 BD59BS7
0.36% KRYS KRYSTAL BIOTECH INC -- $351,210.40 1,982 BD6JX35
0.34% IMVT IMMUNOVANT INC -- $331,118.64 10,182 BJRFSB7
0.33% ALKS ALKERMES PLC -- $319,043.00 11,708 B3P6D26
0.33% LEGN LEGEND BIOTECH CORP-ADR -- $317,954.05 5,585 BMX9K07
0.32% NUVL NUVALENT INC-A -- $314,990.40 4,110 BMVBZD3
0.29% INSM INSMED INC -- $284,264.60 10,405 2614487
0.28% IOVA IOVANCE BIOTHERAPEUTICS INC -- $275,993.40 19,574 BF0DMK7
0.28% RARE ULTRAGENYX PHARMACEUTICAL IN -- $270,198.22 5,771 BJ62Z18
0.27% AXSM AXSOME THERAPEUTICS INC -- $262,765.23 3,319 BYZR4X4
0.27% ACLX ARCELLX INC -- $260,594.55 3,699 BPCJ1Q2
0.27% SWTX SPRINGWORKS THERAPEUTICS INC -- $259,017.00 5,170 BGMGM89
0.26% IBRX IMMUNITYBIO INC -- $255,484.32 46,792 BNSP0B8
0.26% FTRE FORTREA HOLDINGS INC -- $249,377.76 6,222 BRXYZ57
0.26% ARWR ARROWHEAD PHARMACEUTICALS IN -- $249,230.80 8,684 BYQBFJ8
0.25% FOLD AMICUS THERAPEUTICS INC -- $245,502.00 20,700 B19FQ48
0.23% XENE XENON PHARMACEUTICALS INC -- $227,298.00 5,286 BRJ3GY4
0.23% IDYA IDEAYA BIOSCIENCES INC -- $226,251.44 5,224 BK0VHF6
0.22% CRNX CRINETICS PHARMACEUTICALS IN -- $216,773.97 4,879 BDD19F8
0.22% -- ACADIA PHARMACEUTICALS INC COMMON STOCK USD 0.0001 -- $210,191.80 11,549 --
0.21% DNLI DENALI THERAPEUTICS INC -- $202,549.04 9,752 BD2B4V0
0.20% ARVN ARVINAS INC -- $197,226.76 4,772 BDZ30Q0
0.20% BEAM BEAM THERAPEUTICS INC -- $194,353.08 5,723 BK6L288
0.19% SMMT SUMMIT THERAPEUTICS INC -- $184,406.25 49,175 BMTVQS7
0.19% NTLA INTELLIA THERAPEUTICS INC -- $182,006.72 6,736 BYZM6C2
0.19% MRUS MERUS NV -- $181,550.75 4,057 BZBY005
0.18% ALPN ALPINE IMMUNE SCIENCES INC -- $177,558.10 4,594 BYX38M1
0.18% APGE APOGEE THERAPEUTICS INC -- $177,426.55 2,605 BM9HHL5
0.18% VCEL VERICEL CORP -- $177,084.72 3,384 BSBMN89
0.18% RYTM RHYTHM PHARMACEUTICALS INC -- $176,061.27 4,213 BF2YWG4
0.18% RCKT ROCKET PHARMACEUTICALS INC -- $172,846.75 6,343 BDFKQ07
0.18% KYMR KYMERA THERAPEUTICS INC -- $172,048.11 4,283 BMPRZV5
0.17% KROS KEROS THERAPEUTICS INC -- $163,072.52 2,522 BM7V485
0.17% DYN DYNE THERAPEUTICS INC -- $162,022.50 5,685 BN15WD1
0.17% RXRX RECURSION PHARMACEUTICALS-A -- $161,896.23 15,919 BM9FJ13
0.17% VERA VERA THERAPEUTICS INC -- $161,294.40 3,680 BL55460
0.16% PTCT PTC THERAPEUTICS INC -- $158,033.92 5,368 B17VCN9
0.16% SANA SANA BIOTECHNOLOGY INC -- $154,500.00 15,450 BMFJJ97
0.16% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $153,609.28 2,416 BLCD809
0.16% GH GUARDANT HEALTH INC -- $153,198.80 8,530 BFXC911
0.15% AMPH AMPHASTAR PHARMACEUTICALS IN -- $146,662.40 3,370 BNFWZS4
0.15% -- STRUCTURE THERAPEUTICS INC ADR USD 0.0001 -- $146,408.92 3,412 --
0.14% TWST TWIST BIOSCIENCE CORP -- $139,712.96 4,052 BGKG6G7
0.14% RNA AVIDITY BIOSCIENCES INC -- $137,855.96 5,588 BMWHPY1
0.14% SNDX SYNDAX PHARMACEUTICALS INC -- $137,381.85 5,955 BN7Q7R7
0.14% MYGN MYRIAD GENETICS INC -- $134,798.60 6,299 2614153
0.14% JANX JANUX THERAPEUTICS INC -- $134,540.16 3,548 BMFX8Y7
0.14% HRMY HARMONY BIOSCIENCES HOLDINGS -- $133,309.04 3,977 BKSGZN7
0.13% SUPN SUPERNUS PHARMACEUTICALS INC -- $129,359.16 3,834 B72ZBG4
0.13% GERN GERON CORP -- $126,663.77 38,267 2370381
0.13% -- 4D MOLECULAR THERAPEUTICS INC COMMON STOCK USD 0.0001 -- $125,150.43 3,489 --
0.12% -- ARDELYX INC COMMON STOCK USD 0.000001 -- $120,842.28 16,308 --
0.12% MORF MORPHIC HOLDING INC -- $120,571.34 3,506 BK8M4J4
0.12% EWTX EDGEWISE THERAPEUTICS INC -- $117,189.00 6,525 BKY5JZ8
0.12% INBX INHIBRX INC -- $116,733.15 3,321 BK1MBC3
0.12% -- PROTAGONIST THERAPEUTICS INC COMMON STOCK USD 0.00001 -- $116,283.84 4,083 --
0.12% AGIO AGIOS PHARMACEUTICALS INC -- $114,645.44 3,937 BCBVTX1
0.12% VCYT VERACYTE INC -- $114,290.64 5,262 BFTWZY0
0.12% DVAX DYNAVAX TECHNOLOGIES CORP -- $113,601.14 9,154 BRJZSK0
0.12% KURA KURA ONCOLOGY INC -- $112,963.12 5,336 BYZD465
0.11% NVCR NOVOCURE LTD -- $109,858.56 7,504 BYSS4X4
0.11% FUSN FUSION PHARMACEUTICALS INC -- $108,054.90 5,073 BJK0NH0
0.11% -- ADMA BIOLOGICS INC COMMON STOCK USD 0.0001 -- $107,792.82 15,993 --
0.11% AVDL AVADEL PHARMACEUTICALS-ADR -- $105,906.76 6,289 BDTZ028
0.11% ANIP ANI PHARMACEUTICALS INC -- $102,862.44 1,476 BCDWBX6
0.11% IRON DISC MEDICINE INC -- $102,261.90 1,690 BMGJZJ8
0.10% DAWN DAY ONE BIOPHARMACEUTICALS I -- $96,682.17 6,123 BLB0YH0
0.10% AKRO AKERO THERAPEUTICS INC -- $96,455.25 3,945 BK7Y2V9
0.10% XNCR XENCOR INC -- $96,024.86 4,283 BGCYWN8
0.10% VIR VIR BIOTECHNOLOGY INC -- $95,566.20 9,462 BK4PZ38
0.10% PRTA PROTHENA CORP PLC -- $94,727.40 3,765 B91XRN2
0.10% PCRX PACIRA BIOSCIENCES INC -- $94,670.40 3,260 B3X26D8
0.10% IRWD IRONWOOD PHARMACEUTICALS INC -- $94,570.02 10,971 B3MZ6K5
0.09% ABCL ABCELLERA BIOLOGICS INC -- $92,125.82 20,518 BL53SR3
0.09% COLL COLLEGIUM PHARMACEUTICAL INC -- $91,638.40 2,240 BX7RSN3
0.09% GMAB GENMAB A/S -SP ADR -- $89,990.94 2,938 BBC9WC7
0.09% LGND LIGAND PHARMACEUTICALS -- $88,446.07 1,241 2501578
0.09% MNKD MANNKIND CORP -- $87,743.13 18,951 BF081J4
0.09% DCPH DECIPHERA PHARMACEUTICALS IN -- $85,949.16 5,662 BZ1LFB2
0.09% TARS TARSUS PHARMACEUTICALS INC -- $82,933.43 2,399 BMH5RL1
0.08% MIRM MIRUM PHARMACEUTICALS INC -- $82,041.92 3,266 BJDX8Y8
0.08% SAGE SAGE THERAPEUTICS INC -- $80,234.56 4,214 BP4GNK9
0.08% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $79,545.18 9,271 BMCWKZ2
0.08% VRNA VERONA PHARMA PLC - ADR -- $78,573.00 4,762 BYWPZK5
0.08% SRRK SCHOLAR ROCK HOLDING CORP -- $78,115.20 5,056 BFZQ0L8
0.08% VERV VERVE THERAPEUTICS INC -- $77,293.40 5,860 BNKGXX2
0.08% ZNTL ZENTALIS PHARMACEUTICALS INC -- $75,555.06 4,974 BMQ5T49
0.08% RLAY RELAY THERAPEUTICS INC -- $75,014.88 9,193 BN2R582
0.08% BCRX BIOCRYST PHARMACEUTICALS INC -- $74,407.20 14,448 2100362
0.08% ETNB 89BIO INC -- $73,876.92 6,532 BK1K484
0.07% OCUL OCULAR THERAPEUTIX INC -- $71,919.75 7,725 BNZB1X8
0.07% EYPT EYEPOINT PHARMACEUTICALS INC -- $71,211.82 3,422 BMGS7L1
0.07% PACB PACIFIC BIOSCIENCES OF CALIF -- $69,857.88 18,779 B4N8MH9
0.07% RGNX REGENXBIO INC -- $69,090.70 3,115 BZ0G875
0.07% INVA INNOVIVA INC -- $67,749.99 4,431 BDDXF67
0.07% SPRY ARS PHARMACEUTICALS INC -- $67,010.88 6,728 BMCR7V2
0.07% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $65,077.74 6,786 BKX9VD3
0.07% MGNX MACROGENICS INC -- $65,046.08 4,348 BFDV8K0
0.07% ORIC ORIC PHARMACEUTICALS INC -- $63,568.27 4,721 BKVDFF7
0.06% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $61,579.64 1,874 BKC9SX3
0.06% AUTL AUTOLUS THERAPEUTICS PLC -- $61,551.36 9,864 BFMLGR4
0.06% PLRX PLIANT THERAPEUTICS INC -- $61,415.55 4,221 BMDWW66
0.06% -- BICYCLE THERAPEUTICS PLC ADR USD 0.01 -- $61,375.00 2,500 --
0.06% GRFS GRIFOLS SA-ADR -- $56,844.20 8,548 B8K7T65
0.06% ZLAB ZAI LAB LTD-ADR -- $56,195.49 3,471 BD9GVY0
0.06% EOLS EVOLUS INC -- $56,070.00 4,005 BDRJH21
0.06% KNSA KINIKSA PHARMACEUTICALS-A -- $55,991.99 2,801 BD0MGM0
0.06% PRME PRIME MEDICINE INC -- $55,215.68 8,168 BPBJFM7
0.06% TNGX TANGO THERAPEUTICS INC -- $55,039.60 7,148 BP2P6L0
0.06% -- ENLIVEN THERAPEUTICS INC COMMON STOCK USD 0.01 -- $53,784.81 2,887 --
0.05% CGEM CULLINAN ONCOLOGY INC -- $53,154.54 2,998 BM90J52
0.05% -- ALLOGENE THERAPEUTICS INC COMMON STOCK USD 0.001 -- $52,592.32 11,792 --
0.05% WVE WAVE LIFE SCIENCES LTD -- $51,654.08 8,552 BYZG9R0
0.05% CABA CABALETTA BIO INC -- $51,501.45 3,003 BK5MWR1
0.05% AUPH AURINIA PHARMACEUTICALS INC -- $50,670.00 10,134 BFWLC09
0.05% YMAB Y-MABS THERAPEUTICS INC -- $50,638.50 3,069 BG31GH0
0.05% ZYME ZYMEWORKS INC -- $50,531.80 4,906 BPCQZY9
0.05% NRIX NURIX THERAPEUTICS INC -- $49,814.04 3,426 BMVLGP2
0.05% CVAC CUREVAC NV -- $47,857.55 15,691 BN4RD42
0.05% NVAX NOVAVAX INC -- $47,568.80 9,808 BJDQXG4
0.05% COGT COGENT BIOSCIENCES INC -- $47,478.64 7,282 BLR6XK8
0.05% SLRN ACELYRIN INC -- $46,048.50 6,822 BQPF874
0.05% SVRA SAVARA INC -- $46,002.25 9,485 BYXGN81
0.05% GLPG GALAPAGOS NV-SPON ADR -- $45,569.85 1,383 B292NQ7
0.05% PHAT PHATHOM PHARMACEUTICALS INC -- $44,343.65 4,013 BJLKVS6
0.05% OABI OMNIAB INC -- $43,906.94 8,146 BN13S71
0.05% CNTA CENTESSA PHARMACEUTICALS-ADR -- $43,856.10 3,951 BLB0YQ9
0.04% OLMA OLEMA PHARMACEUTICALS INC -- $43,243.20 3,861 BMZ4LN0
0.04% EDIT EDITAS MEDICINE INC -- $42,668.40 5,735 BZ8FPH3
0.04% SIGA SIGA TECHNOLOGIES INC -- $42,338.50 4,981 2107437
0.04% TSHA TAYSHA GENE THERAPIES INC -- $41,536.51 13,103 BNC1BX1
0.04% TRML TOURMALINE BIO INC -- $41,128.40 1,796 BQ80NC6
0.04% FULC FULCRUM THERAPEUTICS INC -- $41,065.86 4,341 BJDX8Z9
0.04% CSTL CASTLE BIOSCIENCES INC -- $40,964.00 1,925 BKLCWZ3
0.04% TVTX TRAVERE THERAPEUTICS INC -- $40,904.11 5,333 BLFGJD5
0.04% -- ALECTOR INC COMMON STOCK USD 0.0001 -- $40,796.80 6,710 --
0.04% ALXO ALX ONCOLOGY HOLDINGS INC -- $39,843.72 3,492 BLN7XQ1
0.04% -- ANAPTYSBIO INC COMMON STOCK USD 0.001 -- $39,830.94 1,863 --
0.04% BMEA BIOMEA FUSION INC -- $38,415.36 2,501 BNKF6N0
0.04% LXRX LEXICON PHARMACEUTICALS INC -- $37,453.38 17,102 BWFZX59
0.04% MLYS MINERALYS THERAPEUTICS INC -- $36,831.96 2,882 BP9N0G0
0.04% HCM HUTCHMED CHINA-ADR -- $36,615.05 2,173 BYXV9H7
0.04% VYGR VOYAGER THERAPEUTICS INC -- $36,375.80 3,805 BY7RB53
0.04% LYEL LYELL IMMUNOPHARMA INC -- $36,326.28 17,807 BN6MB18
0.04% PETQ PETIQ INC -- $35,682.24 2,046 BDH65C8
0.04% REPL REPLIMUNE GROUP INC -- $35,499.75 4,303 BDDVW37
0.03% MRNS MARINUS PHARMACEUTICALS INC -- $33,851.25 3,825 BM8MVZ3
0.03% ITOS ITEOS THERAPEUTICS INC -- $33,017.19 2,507 BMWXFT4
0.03% URGN UROGEN PHARMA LTD -- $32,373.44 2,164 BZ7PJQ1
0.03% KALV KALVISTA PHARMACEUTICALS INC -- $32,257.98 2,914 BD06CS0
0.03% CRBU CARIBOU BIOSCIENCES INC -- $31,733.76 6,198 BNYJR68
0.03% TBPH THERAVANCE BIOPHARMA INC -- $31,453.91 3,491 BMNDK09
0.03% MXCT MAXCYTE INC -- $31,363.20 7,260 BKMQF66
0.03% HROW HARROW INC -- $31,315.80 2,460 BHNDW86
0.03% ABUS ARBUTUS BIOPHARMA CORP -- $30,555.20 11,752 BZ0QMB7
0.03% RVNC REVANCE THERAPEUTICS INC -- $30,539.08 6,182 BJFSR99
0.03% ADPT ADAPTIVE BIOTECHNOLOGIES -- $29,382.63 10,167 BJ5FZ74
0.03% -- ANAVEX LIFE SCIENCES CORP COMMON STOCK USD 0.001 -- $29,115.24 5,754 --
0.03% MGTX MEIRAGTX HOLDINGS PLC -- $27,671.76 4,456 BFYQFJ2
0.03% THRD THIRD HARMONIC BIO INC -- $26,800.10 2,830 BNNPQY8
0.03% TERN TERNS PHARMACEUTICALS INC -- $26,672.80 4,330 BMDJ0C9
0.03% PGEN PRECIGEN INC -- $25,295.25 17,445 BKM5C84
0.03% NAUT NAUTILUS BIOTECHNOLOGY INC -- $24,284.59 8,767 BNG1NK8
0.02% VTYX VENTYX BIOSCIENCES INC -- $24,108.17 4,153 BMG99Y1
0.02% -- AMARIN CORP PLC ADR USD 10 -- $24,043.97 27,040 --
0.02% AVIR ATEA PHARMACEUTICALS INC -- $23,592.00 5,898 BLN9Z50
0.02% HUMA HUMACYTE INC -- $22,506.00 7,260 BMYTJP4
0.02% ERAS ERASCA INC -- $21,813.34 10,589 BNLYBF3
0.02% -- RAPT THERAPEUTICS INC COMMON STOCK USD -- $21,512.37 2,409 --
0.02% ACIU AC IMMUNE SA -- $20,982.75 6,925 BZC0D70
0.02% ATAI ATAI LIFE SCIENCES NV -- $20,826.65 11,635 BN6M8F1
0.02% -- XERIS BIOPHARMA HOLDINGS INC COMMON STOCK USD 0.0001 -- $19,749.24 9,681 --
0.02% EXAI EXSCIENTIA PLC -- $19,542.18 3,381 BP48134
0.02% CHRS COHERUS BIOSCIENCES INC -- $18,885.68 7,804 BRK0149
0.02% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $18,610.50 1,425 BL95N25
0.02% BLUE BLUEBIRD BIO INC -- $18,210.47 13,341 BBFL7S1
0.02% QURE UNIQURE NV -- $18,145.14 3,354 BJFSR88
0.02% VNDA VANDA PHARMACEUTICALS INC -- $15,680.59 4,031 B12W3P6
0.02% OVID OVID THERAPEUTICS INC -- $15,106.65 4,953 BYPFK63
0.01% AMLX AMYLYX PHARMACEUTICALS INC -- $13,677.12 4,749 BPCK358
0.01% -- ACHILLION PHARMACEUTICALS INC - CVR -- $11,641.22 25,307 --
0.01% ME 23ANDME HOLDING CO -CLASS A -- $11,283.41 22,107 BM9CKX3
0.01% ACRS ACLARIS THERAPEUTICS INC -- $6,264.72 4,972 BYV2W40
-- -- RENEO PHARMACEUTICALS INC COMMON STOCK USD 0.0001 -- $3,852.75 2,335 --
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $1,761.30 9,785 BM9HFX3
-- -- TREASURY BILL -- $14,715,740.25 15,000,000 BRYQ9Y9
-- -- NET OTHER ASSETS (LIABILITIES) -- $14,363,313.35 14,363,313 --

Index

as of 12/29/2023

  • Total Number of Companies225
  • Price/Earnings Ratio--
  • Price/Book Ratio4.289
  • Dividend Yield ( % )0.79
  • Avg. Index Market Capitalization$6.63 billion
About the Index

The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.